Business Wire

TERRAFORMATION

21.9.2022 15:09:38 CEST | Business Wire | Press release

Share
New Alliance Launched to Tackle Global Seed Shortage and Scale Reforestation

Terraformation, the world’s first global forest carbon accelerator, today announces the launch of the Seed to Forest Alliance, with American Forests, Ecosystem Restoration Camps and One Tree Planted as founding members, as well as 1t.org US as an advisory partner.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220915005905/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Estimated Number of seed banks still needed per country based on low, medium and high “need for seeds scenarios". Source: Terraformation

Launching at Climate Week NYC 2022, the Alliance supports biodiverse, native reforestation by providing a network to connect forestry teams with financial and technical support; members, who will include corporates, NGOs, and philanthropists, will contribute to research and thought leadership to accelerate reforestation, and share results, best practices and expertise to help the reforestation movement overcome the largest bottlenecks to scale.

The Alliance will initially focus on inadequate seed supply as a barrier to reforestation at scale. New research published today by Terraformation sheds light on the significant scale of upgrades required in the world’s existing seed banking infrastructure to meet global restoration goals.

In recent years, global companies have committed to planting over 3.6 billion trees in their sustainability plans. At COP26, $7.2 billion of private investment was committed to protect and restore forests. However, these targets are not achievable without investment and innovation in global seed banking infrastructure.

Yishan Wong, founder and CEO of Terraformation, said: “Lasting climate solutions only come from collective action across diverse stakeholders. We’re incredibly excited to be working with organizations with the expertise, influence and determination to have a real impact on reforestation around the world. Native ecosystem restoration — with the right plants in the right places — is the most effective and immediately scalable carbon capture solution. Together, we can restore the future of our planet by conserving one of our most valuable resources at the heart of restoration: the seeds.”

Kevin O’Hara, Lead of 1t.org US at American Forests, added: “Time and time again we hear the real and immediate challenges in finding the seeds necessary to reach our ambitious national reforestation goals. 1t.org US is proud to support the work the Seed to Forest Alliance will do to help lift up public, private and NGO efforts to ramp up seed supply here in the US and around the world.”

New research reveals urgency for global seed bank network

Against this backdrop, Terraformation has published The Global Seed Bank Index, the first global review of seed banking infrastructure. The report analyzed the number of seed banks needed to meet the “global restoration potential,” defined as the area of land in the world available for ecological restoration.

The research found that a global decentralized seed bank network would drastically improve restoration outcomes, preserve threatened species, and benefit local communities.

Key findings include:

  • Currently, 410 seed banks store native species for ecosystem restoration across 96 countries, but more are needed in almost all countries. Establishing larger regional seed banks could help meet the need for seeds more efficiently.
  • More than half of the world’s countries have no known seed banks.
  • While the United States, Australia, Brazil and China have the most seed banks, they also need the most new seed banks to meet their restoration potential within 10 years.
  • The restoration movement will also need to train hundreds of thousands of new seed collectors to preserve and restore threatened biodiversity.
  • The tropics and biodiversity hotspots are the highest priority locations for additional seed banking capacity given their high impact on biodiversity and climate regulation.

Following the study, Terraformation is calling on:

  • Businesses to invest in seed banks in their sustainability plans: seed banks are a tangible restoration solution that directly support the UN’s Sustainable Development Goals.
  • Governments to support seed banks as a natural resource management strategy: government support at any level can help create a well-connected and scalable decentralized network with locally adapted, resilient seeds.
  • Local restoration organizations to prioritize seed banking: people already doing restoration on the ground can add seed banking to their restoration toolkits and scale their work with higher efficiency. 

Seed to Forest Alliance

Terraformation and its Alliance members are committed to scaling solutions to the largest bottlenecks to native forest restoration. Four of the largest bottlenecks are inadequate seed supplies, a lack of on-the-ground technical expertise, data accessibility, and insufficient financing. The Alliance will first focus on seed supply, connecting forestry groups with the funding, technology and training to establish local seed supplies and enable biodiverse reforestation at scale.

The Alliance is underpinned by three guiding principles:

  • Biodiversity and ecological resilience: the Alliance will only support native, biodiverse forest restoration in accordance with the IUCN Global Standard for Nature-based Solutions. It does not support monocultures or destructive forestry practices.
  • Community: the Alliance believes communities are at the heart of resilient and just land restoration. It supports forest restoration projects in alignment with UN Sustainable Development Goals, especially with regard to gender equality, decent work, human health and well-being, and elimination of poverty.
  • Measurable impact and transparency: the Alliance prioritizes impact, and as such will set quantifiable goals and transparently report progress.

The Global Seed Bank Index is available to download here.

- ENDS -

About Terraformation

Terraformation is dedicated to restoring the world's forests to stabilize our climate, revive ecosystems, and build thriving communities.

It is launching a forest carbon accelerator, supporting early-stage forestry teams to launch, build, and scale biodiverse reforestation projects and produce high-quality, verified carbon credits.

Terraformation’s partner network spans five continents and includes diverse landowners and organizations. It was founded in 2019 by Yishan Wong, former CEO of Reddit.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220915005905/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press release

Data from the Registrational Phase 3 G-HOPE-001 Study of Arcotatug Tavatecan, a Novel, Potential Best-in-Class Claudin (CLDN)18.2 ADC, were Highlighted in a Late-Breaking Presentation at ESMO 2026Arcotatug Tavatecan Met Dual Primary Endpoints of Overall Survival and Progression-Free Survival, Showing Significant Improvements vs. Treatment of Physician’s Choice in Patients with Previously Treated CLDN18.2-Positive Advanced Gastric CancerFindings to Support Planned Regulatory Filing in Japan and Continued Global Development of Arcotatug Tavatecan in CLDN18.2-Positive Cancers Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye